• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在原发性感染附近的时间点,对感染 HIV 的个体中由 HLA I 等位基因识别的 HIV-1 CTL 表位的动力学:Provir/Latitude45 研究。

Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.

机构信息

University Hospital of Bordeaux and CNRS UMR 5234, Bordeaux, France.

University Hospital of Bordeaux and CNRS UMR 5164, Bordeaux, France.

出版信息

PLoS One. 2014 Jun 25;9(6):e100452. doi: 10.1371/journal.pone.0100452. eCollection 2014.

DOI:10.1371/journal.pone.0100452
PMID:24964202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070993/
Abstract

In patients responding successfully to ART, the next therapeutic step is viral cure. An interesting strategy is antiviral vaccination, particularly involving CD8 T cell epitopes. However, attempts at vaccination are dependent on the immunogenetic background of individuals. The Provir/Latitude 45 project aims to investigate which CTL epitopes in proviral HIV-1 will be recognized by the immune system when HLA alleles are taken into consideration. A prior study (Papuchon et al, PLoS ONE 2013) showed that chronically-infected patients under successful ART exhibited variations of proviral CTL epitopes compared to a reference viral strain (HXB2) and that a generic vaccine may not be efficient. Here, we investigated viral and/or proviral CTL epitopes at different time points in recently infected individuals of the Canadian primary HIV infection cohort and assessed the affinity of these epitopes for HLA alleles during the study period. An analysis of the results confirms that it is not possible to fully predict which epitopes will be recognized by the HLA alleles of the patients if the reference sequences and epitopes are taken as the basis of simulation. Epitopes may be seen to vary in circulating RNA and proviral DNA. Despite this confirmation, the overall variability of the epitopes was low in these patients who are temporally close to primary infection.

摘要

在对 ART 治疗有反应的患者中,下一步的治疗策略是实现病毒治愈。一种有趣的策略是抗病毒疫苗接种,特别是涉及 CD8 T 细胞表位。然而,疫苗接种的尝试取决于个体的免疫遗传背景。Provir/Latitude 45 项目旨在研究在考虑 HLA 等位基因的情况下,前病毒 HIV-1 中的哪些 CTL 表位会被免疫系统识别。先前的一项研究(Papuchon 等人,PLoS ONE 2013)表明,在成功接受 ART 的慢性感染患者中,与参考病毒株(HXB2)相比,前病毒 CTL 表位存在变异,而通用疫苗可能效率不高。在这里,我们研究了加拿大原发性 HIV 感染队列中近期感染个体在不同时间点的病毒和/或前病毒 CTL 表位,并评估了这些表位在研究期间与 HLA 等位基因的亲和力。结果分析证实,如果以参考序列和表位为模拟基础,不可能完全预测哪些表位将被患者的 HLA 等位基因识别。表位可能在循环 RNA 和前病毒 DNA 中发生变异。尽管得到了这一确认,但在这些与原发性感染时间接近的患者中,表位的总体变异性较低。

相似文献

1
Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.在原发性感染附近的时间点,对感染 HIV 的个体中由 HLA I 等位基因识别的 HIV-1 CTL 表位的动力学:Provir/Latitude45 研究。
PLoS One. 2014 Jun 25;9(6):e100452. doi: 10.1371/journal.pone.0100452. eCollection 2014.
2
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.Provir/Latitude 45 研究:朝着基于存档 HIV-1 DNA 并根据主要 HLA I 等位基因设计的多表位 CTL 疫苗迈出的一步。
PLoS One. 2019 Feb 27;14(2):e0212347. doi: 10.1371/journal.pone.0212347. eCollection 2019.
3
ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study).ART 治疗患者对 HFVAC 肽表现出适应性免疫反应,这是一种潜在的 HIV-1 治疗性疫苗(Provir/Latitude45 研究)。
Viruses. 2020 Nov 5;12(11):1256. doi: 10.3390/v12111256.
4
Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.抗病毒治疗患者存档 HIV-1 DNA 中的耐药突变和 CTL 表位:一种新的疫苗概念。
PLoS One. 2013 Jul 9;8(7):e69029. doi: 10.1371/journal.pone.0069029. Print 2013.
5
An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.一种针对人类白细胞抗原(HLA)的分子与生物信息学方法,在感染HIV-1的泰国人中鉴定出新型HLA-A11 HIV-1 E亚型细胞毒性T淋巴细胞表位。
AIDS Res Hum Retroviruses. 2001 May 20;17(8):703-17. doi: 10.1089/088922201750236988.
6
Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA.用于鉴定存档的HIV-1前病毒DNA中CTL表位的桑格测序法和新一代测序数据。
PLoS One. 2017 Sep 21;12(9):e0185211. doi: 10.1371/journal.pone.0185211. eCollection 2017.
7
Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients.抗HIV治疗性疫苗、病毒变异性、细胞毒性T淋巴细胞表位及患者遗传学
AIDS Res Hum Retroviruses. 2018 Jan;34(1):27-30. doi: 10.1089/aid.2017.0175. Epub 2017 Oct 12.
8
Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.慢性人类免疫缺陷病毒1型(HIV-1)感染患者中针对HIV-1的HLA-A*3101限制性细胞毒性T淋巴细胞反应的鉴定。
Tissue Antigens. 2005 Oct;66(4):305-13. doi: 10.1111/j.1399-0039.2005.00489.x.
9
Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.针对1型人类免疫缺陷病毒亚型特异性CD8细胞毒性T淋巴细胞的全面筛查以及受HLA - A0207和 - C(W)0304等位基因限制的简并表位的定义。
J Virol. 2002 May;76(10):4971-86. doi: 10.1128/jvi.76.10.4971-4986.2002.
10
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.树突状细胞将 CTL 反应集中于高度保守和拓扑结构重要的 HIV-1 表位。
EBioMedicine. 2021 Jan;63:103175. doi: 10.1016/j.ebiom.2020.103175. Epub 2021 Jan 12.

引用本文的文献

1
Trust as a Determinant Factor for Condom Use among Female Sex Workers in Bali, Indonesia.信任作为印度尼西亚巴厘岛女性性工作者使用避孕套的一个决定性因素。
Trop Med Infect Dis. 2020 Aug 15;5(3):131. doi: 10.3390/tropicalmed5030131.
2
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles.Provir/Latitude 45 研究:朝着基于存档 HIV-1 DNA 并根据主要 HLA I 等位基因设计的多表位 CTL 疫苗迈出的一步。
PLoS One. 2019 Feb 27;14(2):e0212347. doi: 10.1371/journal.pone.0212347. eCollection 2019.
3
Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA.用于鉴定存档的HIV-1前病毒DNA中CTL表位的桑格测序法和新一代测序数据。
PLoS One. 2017 Sep 21;12(9):e0185211. doi: 10.1371/journal.pone.0185211. eCollection 2017.

本文引用的文献

1
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial.基于肽的 HIV-1 治疗性疫苗 Vacc-4x 的安全性和有效性:一项 2 期随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2014 Apr;14(4):291-300. doi: 10.1016/S1473-3099(13)70343-8. Epub 2014 Feb 11.
2
Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.抗病毒治疗患者存档 HIV-1 DNA 中的耐药突变和 CTL 表位:一种新的疫苗概念。
PLoS One. 2013 Jul 9;8(7):e69029. doi: 10.1371/journal.pone.0069029. Print 2013.
3
Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).在 HIV 阴性志愿者中,经皮内或肌内给予 HIV 脂肽疫苗(ANRS VAC16)后诱导的长期 CD4(+)和 CD8(+) T 细胞应答。
Vaccine. 2013 Sep 13;31(40):4406-15. doi: 10.1016/j.vaccine.2013.06.102. Epub 2013 Jul 11.
4
Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.HIV-1 根除研究中病毒储存库测量方法的比较分析。
PLoS Pathog. 2013 Feb;9(2):e1003174. doi: 10.1371/journal.ppat.1003174. Epub 2013 Feb 14.
5
Vaccine-induced CD8+ T cells control AIDS virus replication.疫苗诱导的 CD8+ T 细胞控制艾滋病病毒复制。
Nature. 2012 Nov 1;491(7422):129-33. doi: 10.1038/nature11443. Epub 2012 Sep 30.
6
Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.宿主 HLA 对 HIV 储存库的调节:弥合疫苗和治愈之间的差距。
Curr Opin Virol. 2012 Oct;2(5):599-605. doi: 10.1016/j.coviro.2012.08.003. Epub 2012 Aug 29.
7
The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.HLA 多态性对 HIV-1 CRF01_AE 感染中 Gag 表位识别的影响。
PLoS One. 2012;7(7):e41696. doi: 10.1371/journal.pone.0041696. Epub 2012 Jul 27.
8
Towards an HIV cure: a global scientific strategy.迈向艾滋病治愈:全球科学策略。
Nat Rev Immunol. 2012 Jul 20;12(8):607-14. doi: 10.1038/nri3262.
9
Widespread impact of HLA restriction on immune control and escape pathways of HIV-1.HLA 限制对 HIV-1 免疫控制和逃逸途径的广泛影响。
J Virol. 2012 May;86(9):5230-43. doi: 10.1128/JVI.06728-11. Epub 2012 Feb 29.
10
HIV compartmentalization: a review on a clinically important phenomenon.HIV 分隔化:关于一种具有临床重要性现象的综述
Curr HIV Res. 2012 Mar;10(2):133-42. doi: 10.2174/157016212799937245.